

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 9.16224095 |
| 2 | drug catabolic process (GO:0042737) | 9.09639087 |
| 3 | epoxygenase P450 pathway (GO:0019373) | 8.68451583 |
| 4 | omega-hydroxylase P450 pathway (GO:0097267) | 8.14965073 |
| 5 | glyoxylate metabolic process (GO:0046487) | 7.87781946 |
| 6 | ethanol oxidation (GO:0006069) | 7.35601511 |
| 7 | regulation of fibrinolysis (GO:0051917) | 6.81936418 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.80947018 |
| 9 | L-phenylalanine catabolic process (GO:0006559) | 6.80947018 |
| 10 | complement activation, alternative pathway (GO:0006957) | 6.62506515 |
| 11 | negative regulation of fibrinolysis (GO:0051918) | 6.62064113 |
| 12 | regulation of protein activation cascade (GO:2000257) | 6.41596474 |
| 13 | urea metabolic process (GO:0019627) | 6.36958543 |
| 14 | drug metabolic process (GO:0017144) | 6.31981549 |
| 15 | oxidative demethylation (GO:0070989) | 6.30111761 |
| 16 | L-phenylalanine metabolic process (GO:0006558) | 6.20252973 |
| 17 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.20252973 |
| 18 | bile acid biosynthetic process (GO:0006699) | 6.14820312 |
| 19 | regulation of complement activation (GO:0030449) | 6.03268677 |
| 20 | ethanol metabolic process (GO:0006067) | 5.92342413 |
| 21 | cellular glucuronidation (GO:0052695) | 5.79627856 |
| 22 | nitrogen cycle metabolic process (GO:0071941) | 5.77620774 |
| 23 | bile acid metabolic process (GO:0008206) | 5.72907215 |
| 24 | uronic acid metabolic process (GO:0006063) | 5.67217994 |
| 25 | glucuronate metabolic process (GO:0019585) | 5.67217994 |
| 26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.48400691 |
| 27 | protein carboxylation (GO:0018214) | 5.48400691 |
| 28 | fibrinolysis (GO:0042730) | 5.36788815 |
| 29 | urea cycle (GO:0000050) | 5.34939287 |
| 30 | aromatic amino acid family catabolic process (GO:0009074) | 5.31526039 |
| 31 | phenylpropanoid metabolic process (GO:0009698) | 5.26295266 |
| 32 | blood coagulation, intrinsic pathway (GO:0007597) | 5.18413379 |
| 33 | bile acid and bile salt transport (GO:0015721) | 5.13950616 |
| 34 | S-adenosylmethionine metabolic process (GO:0046500) | 5.08853647 |
| 35 | alkaloid metabolic process (GO:0009820) | 4.95389233 |
| 36 | serine family amino acid catabolic process (GO:0009071) | 4.83144553 |
| 37 | regulation of triglyceride catabolic process (GO:0010896) | 4.68192216 |
| 38 | negative regulation of cholesterol transport (GO:0032375) | 4.64351502 |
| 39 | negative regulation of sterol transport (GO:0032372) | 4.64351502 |
| 40 | protein activation cascade (GO:0072376) | 4.59738600 |
| 41 | complement activation, classical pathway (GO:0006958) | 4.54011972 |
| 42 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.50327320 |
| 43 | imidazole-containing compound metabolic process (GO:0052803) | 4.46956997 |
| 44 | complement activation (GO:0006956) | 4.46941408 |
| 45 | glycine metabolic process (GO:0006544) | 4.28427096 |
| 46 | regulation of plasminogen activation (GO:0010755) | 4.17852230 |
| 47 | negative regulation of blood coagulation (GO:0030195) | 4.16103689 |
| 48 | negative regulation of hemostasis (GO:1900047) | 4.16103689 |
| 49 | opsonization (GO:0008228) | 4.13323068 |
| 50 | amino-acid betaine metabolic process (GO:0006577) | 4.11237793 |
| 51 | hormone catabolic process (GO:0042447) | 4.10909735 |
| 52 | acylglycerol homeostasis (GO:0055090) | 4.10183898 |
| 53 | triglyceride homeostasis (GO:0070328) | 4.10183898 |
| 54 | arginine metabolic process (GO:0006525) | 4.02858017 |
| 55 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.01471815 |
| 56 | high-density lipoprotein particle remodeling (GO:0034375) | 4.00393691 |
| 57 | indole-containing compound catabolic process (GO:0042436) | 3.98707392 |
| 58 | indolalkylamine catabolic process (GO:0046218) | 3.98707392 |
| 59 | tryptophan catabolic process (GO:0006569) | 3.98707392 |
| 60 | phospholipid efflux (GO:0033700) | 3.97594860 |
| 61 | plasma lipoprotein particle remodeling (GO:0034369) | 3.96688600 |
| 62 | protein-lipid complex remodeling (GO:0034368) | 3.96688600 |
| 63 | macromolecular complex remodeling (GO:0034367) | 3.96688600 |
| 64 | tyrosine metabolic process (GO:0006570) | 3.85841040 |
| 65 | acute-phase response (GO:0006953) | 3.78883026 |
| 66 | negative regulation of wound healing (GO:0061045) | 3.76294719 |
| 67 | negative regulation of coagulation (GO:0050819) | 3.75450463 |
| 68 | alpha-amino acid catabolic process (GO:1901606) | 3.74545642 |
| 69 | regulation of humoral immune response (GO:0002920) | 3.71363874 |
| 70 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.71267027 |
| 71 | xenobiotic metabolic process (GO:0006805) | 3.70616556 |
| 72 | cholesterol efflux (GO:0033344) | 3.70543971 |
| 73 | flavonoid metabolic process (GO:0009812) | 3.69368254 |
| 74 | negative regulation of lipase activity (GO:0060192) | 3.68936050 |
| 75 | heme transport (GO:0015886) | 3.68435279 |
| 76 | reverse cholesterol transport (GO:0043691) | 3.66514448 |
| 77 | regulation of cholesterol esterification (GO:0010872) | 3.62282190 |
| 78 | serine family amino acid metabolic process (GO:0009069) | 3.58960779 |
| 79 | negative regulation of protein activation cascade (GO:2000258) | 3.52666341 |
| 80 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.51569479 |
| 81 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.51569479 |
| 82 | phospholipid homeostasis (GO:0055091) | 3.51433561 |
| 83 | glutamate metabolic process (GO:0006536) | 3.50298095 |
| 84 | cellular ketone body metabolic process (GO:0046950) | 3.48088639 |
| 85 | primary alcohol metabolic process (GO:0034308) | 3.47839138 |
| 86 | primary alcohol catabolic process (GO:0034310) | 3.44570938 |
| 87 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.42013560 |
| 88 | intestinal cholesterol absorption (GO:0030299) | 3.41621829 |
| 89 | steroid catabolic process (GO:0006706) | 3.39545720 |
| 90 | aromatic amino acid family metabolic process (GO:0009072) | 3.37358250 |
| 91 | cytolysis (GO:0019835) | 3.36253682 |
| 92 | response to mercury ion (GO:0046689) | 3.29697252 |
| 93 | tryptophan metabolic process (GO:0006568) | 3.28470404 |
| 94 | sodium-independent organic anion transport (GO:0043252) | 3.27527098 |
| 95 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.26708009 |
| 96 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.26708009 |
| 97 | cellular amino acid catabolic process (GO:0009063) | 3.26423999 |
| 98 | monocarboxylic acid catabolic process (GO:0072329) | 3.23523662 |
| 99 | cysteine metabolic process (GO:0006534) | 3.18268444 |
| 100 | intestinal absorption (GO:0050892) | 3.16190603 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.45763567 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.34886320 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.30468923 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.62763835 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.53207634 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.19204005 |
| 7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.24226119 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.01025908 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.93253877 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.60047359 |
| 11 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.30606921 |
| 12 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 2.12036473 |
| 13 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.03941760 |
| 14 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.98741463 |
| 15 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.86768120 |
| 16 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.81149071 |
| 17 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.80686255 |
| 18 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.79846089 |
| 19 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.75591676 |
| 20 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.64744309 |
| 21 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.59112295 |
| 22 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.59043097 |
| 23 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.56910635 |
| 24 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.53231934 |
| 25 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.51828213 |
| 26 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.50063000 |
| 27 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.49891743 |
| 28 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.49771831 |
| 29 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.45205771 |
| 30 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.42666694 |
| 31 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.42577194 |
| 32 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.42013033 |
| 33 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.37662515 |
| 34 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.35475468 |
| 35 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.30772156 |
| 36 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.27193426 |
| 37 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.21915930 |
| 38 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.21436166 |
| 39 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.16697533 |
| 40 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.15995835 |
| 41 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.12335244 |
| 42 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.10799164 |
| 43 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.06813714 |
| 44 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.05664199 |
| 45 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.99097656 |
| 46 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.96995721 |
| 47 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.96434643 |
| 48 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.94559298 |
| 49 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.93721534 |
| 50 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.90564391 |
| 51 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.90564391 |
| 52 | AR_20517297_ChIP-Seq_VCAP_Human | 0.89972192 |
| 53 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.89056974 |
| 54 | CBP_21632823_ChIP-Seq_H3396_Human | 0.88199591 |
| 55 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.86397144 |
| 56 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.84544971 |
| 57 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.79931155 |
| 58 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.79179615 |
| 59 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.77496404 |
| 60 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.77431591 |
| 61 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.76154777 |
| 62 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.75513320 |
| 63 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.75326729 |
| 64 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.75087753 |
| 65 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.74765086 |
| 66 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.71648132 |
| 67 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.71548469 |
| 68 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.70545375 |
| 69 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.69783839 |
| 70 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.69156644 |
| 71 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.69125243 |
| 72 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.68905144 |
| 73 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.68638754 |
| 74 | STAT3_23295773_ChIP-Seq_U87_Human | 0.68393836 |
| 75 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.68207107 |
| 76 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.67253530 |
| 77 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.67249926 |
| 78 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.67207022 |
| 79 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.66787441 |
| 80 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.66456606 |
| 81 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.65590334 |
| 82 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.63767172 |
| 83 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.63687465 |
| 84 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.63687465 |
| 85 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.63355648 |
| 86 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.62510323 |
| 87 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.62443909 |
| 88 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.62372003 |
| 89 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.62086429 |
| 90 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.62012451 |
| 91 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.62010414 |
| 92 | AR_25329375_ChIP-Seq_VCAP_Human | 0.61871075 |
| 93 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.61582928 |
| 94 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.59602758 |
| 95 | ERA_21632823_ChIP-Seq_H3396_Human | 0.59486252 |
| 96 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.59364225 |
| 97 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.58247840 |
| 98 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.57991016 |
| 99 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.57931031 |
| 100 | NFYA_21822215_ChIP-Seq_K562_Human | 0.57577879 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.84125619 |
| 2 | MP0005360_urolithiasis | 6.42482810 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.41723529 |
| 4 | MP0005365_abnormal_bile_salt | 5.52865644 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.45468608 |
| 6 | MP0001666_abnormal_nutrient_absorption | 4.13294272 |
| 7 | MP0003195_calcinosis | 3.86021965 |
| 8 | MP0003252_abnormal_bile_duct | 3.63716573 |
| 9 | MP0002138_abnormal_hepatobiliary_system | 3.20760500 |
| 10 | MP0003868_abnormal_feces_composition | 3.01956218 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.92652299 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 2.40283404 |
| 13 | MP0005451_abnormal_body_composition | 2.37562891 |
| 14 | MP0003806_abnormal_nucleotide_metabolis | 2.36519856 |
| 15 | MP0009840_abnormal_foam_cell | 2.35760818 |
| 16 | MP0005332_abnormal_amino_acid | 2.34236943 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 2.07081500 |
| 18 | MP0009697_abnormal_copulation | 2.06687994 |
| 19 | MP0001764_abnormal_homeostasis | 2.04230980 |
| 20 | MP0002876_abnormal_thyroid_physiology | 1.92123302 |
| 21 | MP0002118_abnormal_lipid_homeostasis | 1.80240116 |
| 22 | MP0000609_abnormal_liver_physiology | 1.70295107 |
| 23 | MP0003011_delayed_dark_adaptation | 1.47421155 |
| 24 | MP0000537_abnormal_urethra_morphology | 1.26949062 |
| 25 | MP0009053_abnormal_anal_canal | 1.14884751 |
| 26 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.14418413 |
| 27 | MP0005319_abnormal_enzyme/_coenzyme | 1.07658750 |
| 28 | MP0002249_abnormal_larynx_morphology | 1.06851317 |
| 29 | MP0009643_abnormal_urine_homeostasis | 1.06747228 |
| 30 | MP0004043_abnormal_pH_regulation | 1.05863466 |
| 31 | MP0003183_abnormal_peptide_metabolism | 1.04713099 |
| 32 | MP0003315_abnormal_perineum_morphology | 1.02188338 |
| 33 | MP0005636_abnormal_mineral_homeostasis | 0.95359799 |
| 34 | MP0000598_abnormal_liver_morphology | 0.93513922 |
| 35 | MP0004858_abnormal_nervous_system | 0.89556953 |
| 36 | MP0010368_abnormal_lymphatic_system | 0.87877646 |
| 37 | MP0005395_other_phenotype | 0.87304475 |
| 38 | MP0005187_abnormal_penis_morphology | 0.86568429 |
| 39 | MP0000566_synostosis | 0.82034223 |
| 40 | MP0009642_abnormal_blood_homeostasis | 0.78328115 |
| 41 | MP0000604_amyloidosis | 0.78010393 |
| 42 | MP0008872_abnormal_physiological_respon | 0.74455694 |
| 43 | MP0002971_abnormal_brown_adipose | 0.73492455 |
| 44 | MP0003879_abnormal_hair_cell | 0.73014118 |
| 45 | MP0005376_homeostasis/metabolism_phenot | 0.72293278 |
| 46 | MP0002009_preneoplasia | 0.71905038 |
| 47 | MP0001440_abnormal_grooming_behavior | 0.71094140 |
| 48 | MP0002168_other_aberrant_phenotype | 0.70648787 |
| 49 | MP0003656_abnormal_erythrocyte_physiolo | 0.69290153 |
| 50 | MP0005670_abnormal_white_adipose | 0.67365738 |
| 51 | MP0000538_abnormal_urinary_bladder | 0.65956402 |
| 52 | MP0001881_abnormal_mammary_gland | 0.65505487 |
| 53 | MP0005367_renal/urinary_system_phenotyp | 0.65434086 |
| 54 | MP0000516_abnormal_urinary_system | 0.65434086 |
| 55 | MP0001756_abnormal_urination | 0.65206742 |
| 56 | MP0002282_abnormal_trachea_morphology | 0.63860318 |
| 57 | MP0005408_hypopigmentation | 0.62846364 |
| 58 | MP0005535_abnormal_body_temperature | 0.62690951 |
| 59 | MP0003186_abnormal_redox_activity | 0.62300412 |
| 60 | MP0005647_abnormal_sex_gland | 0.62184342 |
| 61 | MP0004782_abnormal_surfactant_physiolog | 0.60873962 |
| 62 | MP0005166_decreased_susceptibility_to | 0.60712424 |
| 63 | MP0003718_maternal_effect | 0.60200137 |
| 64 | MP0008469_abnormal_protein_level | 0.59673692 |
| 65 | MP0002078_abnormal_glucose_homeostasis | 0.59401082 |
| 66 | MP0002736_abnormal_nociception_after | 0.57073024 |
| 67 | MP0009763_increased_sensitivity_to | 0.57048001 |
| 68 | MP0005646_abnormal_pituitary_gland | 0.55190269 |
| 69 | MP0001661_extended_life_span | 0.54957510 |
| 70 | MP0004742_abnormal_vestibular_system | 0.50581178 |
| 71 | MP0001485_abnormal_pinna_reflex | 0.49722969 |
| 72 | MP0005645_abnormal_hypothalamus_physiol | 0.49619770 |
| 73 | MP0005334_abnormal_fat_pad | 0.48524408 |
| 74 | MP0003959_abnormal_lean_body | 0.48480971 |
| 75 | MP0010386_abnormal_urinary_bladder | 0.48341527 |
| 76 | MP0002136_abnormal_kidney_physiology | 0.47260157 |
| 77 | MP0003690_abnormal_glial_cell | 0.45524049 |
| 78 | MP0003638_abnormal_response/metabolism_ | 0.43271993 |
| 79 | MP0008874_decreased_physiological_sensi | 0.42613037 |
| 80 | MP0009764_decreased_sensitivity_to | 0.40796633 |
| 81 | MP0001664_abnormal_digestion | 0.40534926 |
| 82 | MP0002822_catalepsy | 0.40398041 |
| 83 | MP0003953_abnormal_hormone_level | 0.40353997 |
| 84 | MP0002102_abnormal_ear_morphology | 0.37863062 |
| 85 | MP0005448_abnormal_energy_balance | 0.37832788 |
| 86 | MP0005266_abnormal_metabolism | 0.37062643 |
| 87 | MP0003705_abnormal_hypodermis_morpholog | 0.36829481 |
| 88 | MP0003329_amyloid_beta_deposits | 0.35313543 |
| 89 | MP0005551_abnormal_eye_electrophysiolog | 0.34585634 |
| 90 | MP0009115_abnormal_fat_cell | 0.33984489 |
| 91 | MP0001919_abnormal_reproductive_system | 0.33765639 |
| 92 | MP0004924_abnormal_behavior | 0.33713326 |
| 93 | MP0005386_behavior/neurological_phenoty | 0.33713326 |
| 94 | MP0003075_altered_response_to | 0.32875350 |
| 95 | MP0000026_abnormal_inner_ear | 0.31825120 |
| 96 | MP0000249_abnormal_blood_vessel | 0.31052553 |
| 97 | MP0000639_abnormal_adrenal_gland | 0.30915219 |
| 98 | MP0004147_increased_porphyrin_level | 0.29859436 |
| 99 | MP0003866_abnormal_defecation | 0.26764953 |
| 100 | MP0002697_abnormal_eye_size | 0.26054111 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 9.72588165 |
| 2 | Deep venous thrombosis (HP:0002625) | 8.93158364 |
| 3 | Complement deficiency (HP:0004431) | 8.52087778 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 7.84854996 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 7.00013992 |
| 6 | Abnormality of complement system (HP:0005339) | 6.85979173 |
| 7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.81826246 |
| 8 | Conjugated hyperbilirubinemia (HP:0002908) | 6.29696647 |
| 9 | Systemic lupus erythematosus (HP:0002725) | 6.06531727 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 5.93235623 |
| 11 | Joint hemorrhage (HP:0005261) | 5.27763134 |
| 12 | Intrahepatic cholestasis (HP:0001406) | 5.07470757 |
| 13 | Hypolipoproteinemia (HP:0010981) | 4.69680651 |
| 14 | Glomerulonephritis (HP:0000099) | 4.69412923 |
| 15 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.39428057 |
| 16 | Xanthomatosis (HP:0000991) | 4.32160540 |
| 17 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.25256183 |
| 18 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.19633009 |
| 19 | Spontaneous abortion (HP:0005268) | 3.91311019 |
| 20 | Hyperglycinemia (HP:0002154) | 3.90543324 |
| 21 | Nephritis (HP:0000123) | 3.79184311 |
| 22 | Hyperammonemia (HP:0001987) | 3.77902922 |
| 23 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.71659324 |
| 24 | Abnormality of glycine metabolism (HP:0010895) | 3.71659324 |
| 25 | Fat malabsorption (HP:0002630) | 3.68783112 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 3.66912264 |
| 27 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.54404297 |
| 28 | Abnormality of the common coagulation pathway (HP:0010990) | 3.49699484 |
| 29 | Hyperglycinuria (HP:0003108) | 3.38244671 |
| 30 | Abnormality of methionine metabolism (HP:0010901) | 3.24706907 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.13116486 |
| 32 | Generalized aminoaciduria (HP:0002909) | 3.10982671 |
| 33 | Neonatal hypoglycemia (HP:0001998) | 3.03387246 |
| 34 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.92620419 |
| 35 | Abnormality of serum amino acid levels (HP:0003112) | 2.91482827 |
| 36 | Epidermoid cyst (HP:0200040) | 2.86629266 |
| 37 | Osteomalacia (HP:0002749) | 2.86598926 |
| 38 | Delayed CNS myelination (HP:0002188) | 2.80763098 |
| 39 | Abnormality of nucleobase metabolism (HP:0010932) | 2.65360705 |
| 40 | Rickets (HP:0002748) | 2.65234118 |
| 41 | Steatorrhea (HP:0002570) | 2.64413467 |
| 42 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.63764311 |
| 43 | Hemorrhage of the eye (HP:0011885) | 2.60135153 |
| 44 | Abnormality of urine glucose concentration (HP:0011016) | 2.58742494 |
| 45 | Glycosuria (HP:0003076) | 2.58742494 |
| 46 | Fair hair (HP:0002286) | 2.51274775 |
| 47 | Vascular calcification (HP:0004934) | 2.51111284 |
| 48 | Abnormality of vitamin metabolism (HP:0100508) | 2.48108662 |
| 49 | Metabolic acidosis (HP:0001942) | 2.47734149 |
| 50 | Congenital sensorineural hearing impairment (HP:0008527) | 2.44628209 |
| 51 | Ketosis (HP:0001946) | 2.39958119 |
| 52 | Bifid scrotum (HP:0000048) | 2.38347078 |
| 53 | Hypercholesterolemia (HP:0003124) | 2.33263202 |
| 54 | Hyperbilirubinemia (HP:0002904) | 2.25811617 |
| 55 | Alkalosis (HP:0001948) | 2.24590672 |
| 56 | Proximal tubulopathy (HP:0000114) | 2.21387210 |
| 57 | Cerebral palsy (HP:0100021) | 2.20064666 |
| 58 | Gingival bleeding (HP:0000225) | 2.14202264 |
| 59 | Cardiovascular calcification (HP:0011915) | 2.14061321 |
| 60 | Reduced antithrombin III activity (HP:0001976) | 2.13838337 |
| 61 | Pulmonary embolism (HP:0002204) | 2.10341163 |
| 62 | Hyperphosphaturia (HP:0003109) | 2.08951281 |
| 63 | Blue irides (HP:0000635) | 2.08813480 |
| 64 | Thrombophlebitis (HP:0004418) | 2.07153272 |
| 65 | Malnutrition (HP:0004395) | 1.97729479 |
| 66 | Back pain (HP:0003418) | 1.97683608 |
| 67 | Abnormality of proline metabolism (HP:0010907) | 1.96331462 |
| 68 | Hydroxyprolinuria (HP:0003080) | 1.96331462 |
| 69 | Abnormality of purine metabolism (HP:0004352) | 1.92075278 |
| 70 | Purpura (HP:0000979) | 1.82677500 |
| 71 | Generalized hypopigmentation of hair (HP:0011358) | 1.81857997 |
| 72 | Lethargy (HP:0001254) | 1.81627940 |
| 73 | Arthropathy (HP:0003040) | 1.80913974 |
| 74 | Stroke (HP:0001297) | 1.79077790 |
| 75 | Irritability (HP:0000737) | 1.78774237 |
| 76 | Skin nodule (HP:0200036) | 1.77303161 |
| 77 | Ketoacidosis (HP:0001993) | 1.76901835 |
| 78 | Abnormal urine phosphate concentration (HP:0012599) | 1.75929384 |
| 79 | Hypoglycemic coma (HP:0001325) | 1.74291396 |
| 80 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.70731317 |
| 81 | Pancreatitis (HP:0001733) | 1.69613747 |
| 82 | Elevated alkaline phosphatase (HP:0003155) | 1.69088781 |
| 83 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.66590480 |
| 84 | Amyloidosis (HP:0011034) | 1.65266103 |
| 85 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.65009841 |
| 86 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.60563749 |
| 87 | Abnormality of iron homeostasis (HP:0011031) | 1.58190152 |
| 88 | Menorrhagia (HP:0000132) | 1.58166554 |
| 89 | Nephrolithiasis (HP:0000787) | 1.57984607 |
| 90 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.57712194 |
| 91 | Hepatocellular carcinoma (HP:0001402) | 1.57041563 |
| 92 | Acanthocytosis (HP:0001927) | 1.56382310 |
| 93 | Gout (HP:0001997) | 1.56187324 |
| 94 | Potter facies (HP:0002009) | 1.55819763 |
| 95 | Facial shape deformation (HP:0011334) | 1.55819763 |
| 96 | Abnormal tarsal ossification (HP:0008369) | 1.55706117 |
| 97 | Poikilocytosis (HP:0004447) | 1.54604171 |
| 98 | Sensorimotor neuropathy (HP:0007141) | 1.53903524 |
| 99 | Abnormality of secondary sexual hair (HP:0009888) | 1.52997150 |
| 100 | Abnormality of the axillary hair (HP:0100134) | 1.52997150 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPK15 | 4.82839402 |
| 2 | PRKD3 | 4.32839137 |
| 3 | PNCK | 3.81416000 |
| 4 | AKT3 | 3.46689849 |
| 5 | EPHB1 | 3.43460204 |
| 6 | TSSK6 | 3.05856304 |
| 7 | ACVR1B | 2.53379073 |
| 8 | MAPKAPK3 | 2.43046108 |
| 9 | NEK9 | 2.37521816 |
| 10 | MAPK13 | 2.33886388 |
| 11 | CASK | 2.22521551 |
| 12 | CAMK1D | 2.08766083 |
| 13 | MAPKAPK5 | 2.01015503 |
| 14 | FER | 1.97203457 |
| 15 | PIK3CA | 1.94398147 |
| 16 | STK39 | 1.92642983 |
| 17 | TNK2 | 1.89965779 |
| 18 | CAMK1G | 1.80192077 |
| 19 | FGFR4 | 1.73487251 |
| 20 | GRK1 | 1.61150498 |
| 21 | LATS1 | 1.55021004 |
| 22 | ERN1 | 1.45403593 |
| 23 | TRIB3 | 1.39679972 |
| 24 | TAOK3 | 1.37225956 |
| 25 | MAP2K2 | 1.33865301 |
| 26 | EPHA3 | 1.29414196 |
| 27 | NLK | 1.26344730 |
| 28 | EPHA4 | 1.16770510 |
| 29 | RIPK1 | 1.15820982 |
| 30 | MAP2K4 | 1.14329596 |
| 31 | CAMKK2 | 1.10690984 |
| 32 | DDR2 | 1.10222659 |
| 33 | DAPK2 | 1.09626250 |
| 34 | PRKD2 | 1.05592375 |
| 35 | TYRO3 | 1.02562615 |
| 36 | PKN2 | 0.98355000 |
| 37 | OXSR1 | 0.97003370 |
| 38 | PRKACG | 0.96380050 |
| 39 | PTK6 | 0.91909170 |
| 40 | MAP3K12 | 0.90595960 |
| 41 | MST1R | 0.89336966 |
| 42 | PKN1 | 0.83075436 |
| 43 | NTRK3 | 0.82851947 |
| 44 | SIK1 | 0.81030165 |
| 45 | WNK3 | 0.80635355 |
| 46 | SGK223 | 0.80268543 |
| 47 | SGK494 | 0.80268543 |
| 48 | ERBB2 | 0.78803157 |
| 49 | SGK2 | 0.76503664 |
| 50 | MAP3K2 | 0.75800739 |
| 51 | MYLK | 0.73051039 |
| 52 | TAOK1 | 0.72775369 |
| 53 | MELK | 0.72563454 |
| 54 | PRKCG | 0.71690496 |
| 55 | PRKAA2 | 0.66207569 |
| 56 | STK38 | 0.65702874 |
| 57 | DYRK1B | 0.65492434 |
| 58 | RET | 0.64323052 |
| 59 | CAMKK1 | 0.63927457 |
| 60 | PRKCZ | 0.63831276 |
| 61 | PRKACA | 0.62034410 |
| 62 | KSR2 | 0.60466966 |
| 63 | EPHB2 | 0.57218352 |
| 64 | KSR1 | 0.57101430 |
| 65 | FGFR3 | 0.55896287 |
| 66 | MAP3K1 | 0.53152263 |
| 67 | EEF2K | 0.51834883 |
| 68 | WNK4 | 0.49317503 |
| 69 | PRKD1 | 0.47188960 |
| 70 | MAP3K9 | 0.46941705 |
| 71 | PAK3 | 0.46537113 |
| 72 | MAP3K3 | 0.45579838 |
| 73 | IGF1R | 0.45222032 |
| 74 | PRKCA | 0.44319456 |
| 75 | PDPK1 | 0.43328003 |
| 76 | EPHA2 | 0.42181801 |
| 77 | WEE1 | 0.41835097 |
| 78 | MAPK11 | 0.40923317 |
| 79 | PAK2 | 0.40781265 |
| 80 | PINK1 | 0.40276622 |
| 81 | SGK1 | 0.39263091 |
| 82 | TYK2 | 0.37217198 |
| 83 | STK38L | 0.37109329 |
| 84 | MAP3K11 | 0.36871951 |
| 85 | LMTK2 | 0.35532261 |
| 86 | PRKCH | 0.35519586 |
| 87 | FRK | 0.35195181 |
| 88 | MARK2 | 0.34194584 |
| 89 | GRK7 | 0.32487278 |
| 90 | SGK3 | 0.31648717 |
| 91 | CSNK1A1 | 0.29321651 |
| 92 | PRKCE | 0.27668029 |
| 93 | CDC42BPA | 0.27089192 |
| 94 | PRKCI | 0.26338268 |
| 95 | MAP2K1 | 0.26055444 |
| 96 | BCKDK | 0.26046678 |
| 97 | MET | 0.25511076 |
| 98 | RPS6KA3 | 0.24958981 |
| 99 | MAPKAPK2 | 0.24841680 |
| 100 | SRC | 0.23463151 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.67428661 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.10351135 |
| 3 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.45599883 |
| 4 | Retinol metabolism_Homo sapiens_hsa00830 | 3.40042412 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.21386691 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.20114690 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.13876176 |
| 8 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.97653087 |
| 9 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.91579740 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.58930711 |
| 11 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.51280768 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.47761851 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.46475135 |
| 14 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.37892445 |
| 15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.37555027 |
| 16 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.31243593 |
| 17 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.27244022 |
| 18 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.25098236 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 2.21965258 |
| 20 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.18952082 |
| 21 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.06807804 |
| 22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.93288377 |
| 23 | Bile secretion_Homo sapiens_hsa04976 | 1.92025290 |
| 24 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.82643635 |
| 25 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.66250112 |
| 26 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.54560981 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.47485685 |
| 28 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.46530294 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.46178338 |
| 30 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.45029640 |
| 31 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.44658900 |
| 32 | Peroxisome_Homo sapiens_hsa04146 | 1.43542024 |
| 33 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.41778467 |
| 34 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.29720380 |
| 35 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.23860236 |
| 36 | Prion diseases_Homo sapiens_hsa05020 | 1.19078140 |
| 37 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.18464897 |
| 38 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.13766941 |
| 39 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.10501113 |
| 40 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.04658839 |
| 41 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.03629795 |
| 42 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.93171615 |
| 43 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.91648638 |
| 44 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.91227811 |
| 45 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.88272221 |
| 46 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.83832734 |
| 47 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.81828748 |
| 48 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.77521584 |
| 49 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.76707322 |
| 50 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.74605133 |
| 51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.73995279 |
| 52 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.72927302 |
| 53 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.70325744 |
| 54 | ABC transporters_Homo sapiens_hsa02010 | 0.67675000 |
| 55 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.67656400 |
| 56 | Carbon metabolism_Homo sapiens_hsa01200 | 0.62136856 |
| 57 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.54750464 |
| 58 | Sulfur relay system_Homo sapiens_hsa04122 | 0.50749334 |
| 59 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.50030471 |
| 60 | Lysine degradation_Homo sapiens_hsa00310 | 0.49145170 |
| 61 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.48046618 |
| 62 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.47939634 |
| 63 | Mineral absorption_Homo sapiens_hsa04978 | 0.45425216 |
| 64 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.42742168 |
| 65 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41739989 |
| 66 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.33283297 |
| 67 | Pertussis_Homo sapiens_hsa05133 | 0.20401752 |
| 68 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.19807384 |
| 69 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.18400036 |
| 70 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.16301759 |
| 71 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.14374036 |
| 72 | Insulin resistance_Homo sapiens_hsa04931 | 0.13794478 |
| 73 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.13646784 |
| 74 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10767267 |
| 75 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.09658724 |
| 76 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.09170729 |
| 77 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.08428550 |
| 78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.02437467 |
| 79 | Galactose metabolism_Homo sapiens_hsa00052 | 0.00851439 |
| 80 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.2260685 |
| 81 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.2017548 |
| 82 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | -0.1951712 |
| 83 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1575803 |
| 84 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1502289 |
| 85 | Pentose phosphate pathway_Homo sapiens_hsa00030 | -0.1272271 |
| 86 | Pancreatic secretion_Homo sapiens_hsa04972 | -0.1207147 |
| 87 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | -0.1142688 |
| 88 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1108534 |
| 89 | Cocaine addiction_Homo sapiens_hsa05030 | -0.0992608 |
| 90 | Amoebiasis_Homo sapiens_hsa05146 | -0.0854081 |
| 91 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0822026 |
| 92 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.0788263 |
| 93 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0749879 |
| 94 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.0642699 |
| 95 | Fatty acid elongation_Homo sapiens_hsa00062 | -0.0579166 |
| 96 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0333621 |
| 97 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0272441 |
| 98 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0151582 |
| 99 | Steroid biosynthesis_Homo sapiens_hsa00100 | -0.0142262 |
| 100 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0016450 |

